Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-03T01:20:58.578Z Has data issue: false hasContentIssue false

9 - Conventional and second generation monoamine oxidase inhibitors in treatment-resistant depression

from Part III - Treatment approaches

Published online by Cambridge University Press:  25 March 2010

Jay D. Amsterdam
Affiliation:
University of Pennsylvania
Mady Hornig
Affiliation:
University of California, Irvine
Andrew A. Nierenberg
Affiliation:
Harvard Medical School
Get access

Summary

Introduction

The treatment of patients with treatment-resistant depressive illness can be frustrating to clinicians as, by definition, conventional antidepressant treatments have failed. This, despite having effective treatment-resistant depression therapies such as tricyclic antidepressants (TCAs), monoamine oxidase inhibitors (MAOIs), reversible inhibitors of monoamine oxidase A (RIMAs); dopamine reuptake inhibitors, specific serotonin reuptake inhibitors (SSRIs), 5-HT2 antagonists, serotonin–noradrenaline reuptake inhibitors (SNRIs), and electroconvulsive treatment (ECT). This chapter will examine the efficacy of conventional and second generation monoamine oxidase inhibitors in treatment-resistant depression.

Both classical monoamine oxidase inhibitors and reversible inhibitors of monoamine oxidase A have been underutilized in the treatment of treatment-resistant depression. There are several potential reasons for this including the food and drug interactions found in classical monoamine oxidase inhibitor treatment (Blackwell et al., 1967) and early negative research Wndings including the Medical Research Council study of 1965, where the monoamine oxidase inhibitor phenelzine was found to be less effective than imipramine or electroconvulsive therapy (Medical Research Council, 1965). The conclusion was that MAOIs are ‘drugs of narrow therapeutic utility and have not emerged as drug of choice in the treatment of any type of depressive illness’ (Simpson & Cabot, 1974, p. 155).

Further research has now shown that both the specific and non-specific types of monamine oxidase inhibitors have therapeutic utility and are starting to become more widely used in the treatment of treatment-resistant depression (Martin et al., 1994).

Classical monoamine oxidase inhibitors (Fig. 9.1)

The three classical monoamine oxidase inhibitors used at present are phenelzine, tranylcypromine, and isocarboxazid.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×